Furthermore, recurrent focal chromosome amplifications in CCND1, FGF19, VEGFA, MYC, or MET genes, as well as changes in epigenetic regulation, oxidative stress, and the AKT–mTOR and MAPK pathways have been reported in HCC [26, 27]. The gene discussed is FGF19; the disease is hepatocellular carcinoma.